4G31 image
Entry Detail
PDB ID:
4G31
Title:
Crystal Structure of GSK6414 Bound to PERK (R587-R1092, delete A660-T867) at 2.28 A Resolution
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2012-07-13
Release Date:
2012-08-08
Method Details:
Experimental Method:
Resolution:
2.28 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 61 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Eukaryotic translation initiation factor 2-alpha kinase 3
Chain IDs:A
Chain Length:299
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK).
J.Med.Chem. 55 7193 7207 (2012)
PMID: 22827572 DOI: 10.1021/jm300713s

Abstact

Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous disease states. Evidence that PERK is implicated in tumorigenesis and cancer cell survival stimulated our search for small molecule inhibitors. Through screening and lead optimization using the human PERK crystal structure, we discovered compound 38 (GSK2606414), an orally available, potent, and selective PERK inhibitor. Compound 38 inhibits PERK activation in cells and inhibits the growth of a human tumor xenograft in mice.

Legend

Protein

Chemical

Disease

Primary Citation of related structures